Santa Fe Partners’s Pacira BioSciences PCRX Stock Holding History

Santa Fe Partners’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-31,607	Closed	-$2.43M	–	241
2015 Q4	$2.43M	Sell	31,607 -8,956	-22%	-$507K	0.4%	94
2015 Q3	$1.67M	Buy	40,563 +11,178	+38%	+$685K	0.22%	205
2015 Q2	$2.08M	Buy	+29,385	New	+$2.31M	0.28%	133
2015 Q1	–	Sell	-24,280	Closed	-$2.15M	–	567
2014 Q4	$2.15M	Buy	+24,280	New	+$2.3M	0.27%	155
2014 Q3	–	Sell	-16,022	Closed	-$1.47M	–	574
2014 Q2	$1.47M	Buy	+16,022	New	+$1.22M	0.22%	196

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Santa Fe Partners's PCRX Position: Q1 2016 in Review

Santa Fe Partners sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 31,607 shares — an estimated $2.43M sold.

Santa Fe Partners first reported a position in PCRX in Q2 2014 and held it in 5 quarters. The position peaked at $2.43M in Q4 2015. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

Santa Fe Partners reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 31,607 Pacira BioSciences shares in Q1 2016, an estimated $2.43M.
Santa Fe Partners first reported a position in Pacira BioSciences in Q2 2014 and held it in 5 quarters.
Santa Fe Partners's Pacira BioSciences position peaked at $2.43M in Q4 2015.
180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.